Primary hyperoxaluria in a compound heterozygote infant

World J Pediatr. 2011 May;7(2):173-5. doi: 10.1007/s12519-010-0214-z. Epub 2010 Jun 12.

Abstract

Background: Primary hyperoxaluria type 1 is a rare disorder caused by a defect in the hepatic metabolism of glyoxylate. Cases presenting in infancy are very uncommon and often have a severe course leading to early end-stage renal failure.

Methods: We treated a case of early presentation of primary hyperoxaluria type 1 and reviewed the relevant literature.

Results: A 4-month-old female infant was admitted to our hospital because of acute renal failure and nephrocalcinosis. Mutational analysis of alanine-glyoxylate aminotransferase gene revealed compound heterozygosity in the infant, confirming the development of primary hyperoxaluria type 1. A few weeks later, the condition of the infant worsened during an interdialytic period and died.

Conclusions: Interest of this case is based on the coexistence of two mutations of alanine-glyoxylate aminotransferase gene recently reported, and it confirms the severe course of the disease when it presents in infancy. It also highlights the importance of the association of nephrocalcinosis and urolithiasis as key diagnostic manifestations of primary hyperoxaluria type 1.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Mutational Analysis
  • Fatal Outcome
  • Female
  • Humans
  • Hyperoxaluria, Primary / complications
  • Hyperoxaluria, Primary / genetics*
  • Hyperoxaluria, Primary / physiopathology
  • Hyperoxaluria, Primary / therapy
  • Infant
  • Nephrocalcinosis / etiology
  • Nephrocalcinosis / genetics
  • Transaminases / genetics
  • Urolithiasis / etiology
  • Urolithiasis / genetics

Substances

  • Transaminases
  • Alanine-glyoxylate transaminase